Lucy Richardson (née Thornton-Jones) is currently the Rare Disease HTA Sub-Team Lead at Pfizer, where they contribute to health technology assessment in the rare disease sector. Previously, they served as the UK Health & Value HTA Manager at Pfizer and worked as a Health Outcomes & HTA Manager at Otsuka Pharmaceuticals (UK) Ltd. Lucy began their career as a Senior Account Executive at Red Door Unlimited before transitioning into health analytics as an Analyst at IQVIA. They hold a bachelor's degree in Medical Biology from Edinburgh University and a master's degree in Health Economics from City University.
This person is not in any teams
This person is not in any offices